chevron_leftBack
As of 6 June 2026, Integrum AB (publ) has a market cap of $23.05M USD, ranking #36112 globally and #524 in Sweden.
It ranks #3245 in the Healthcare sector, and #687 in the Medical Devices industry.
Key Stats
Market Cap
$23.05MUSD
216.01M SEK
Enterprise Value
$20.21MUSD
189.44M SEK
Revenue (TTM)
$10.47MUSD
98.18M SEK
EBITDA (TTM)
-$4.37MUSD
-40.97M SEK
Net Income (TTM)
-$4.04MUSD
-37.83M SEK
EBITDA Margin
-42%
Profit Margin
-39%
PS Ratio
2.2
PB Ratio
1.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Martin Hillsten
open_in_new
Employees
35
Founded
1990
Website
integrum.se
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.6% | -3.6% | 15% | -23% | -3.3% | -39% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
INTEG-B
Integrum AB
ISIN: SE0009807266
Shares Out.:
Shares Outstanding:
26.028M1
Shares Float:
18.253M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
7.97 SEK |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Integrum AB (publ)
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. It also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was incorporated in 1990 and is headquartered in Mölndal, Sweden.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
STO: GETI-B
|
$5.59B
24K%
52.4B SEK
|
22.2
|
|
|
S
STO: SCIB
|
$4.85B
21K%
45.5B SEK
|
-
|
|
STO: EKTA-B
|
$2.23B
10K%
20.86B SEK
|
-
|
|
STO: VITR
|
$1.59B
7K%
14.87B SEK
|
-
|
|
STO: BONEX
|
$1.53B
7K%
14.32B SEK
|
78.5
|
|
STO: XVIVO
|
$907.38M
4K%
8.5B SEK
|
115.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
752K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
697K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
690K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
549K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
524K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
442K%
|
22.2
|
chevron_leftBack